Department of Pediatrics, Duke Children's Hospital, Durham, NC 27710, USA.
Expert Rev Respir Med. 2012 Aug;6(4):377-84. doi: 10.1586/ers.12.31.
Extracorporeal membrane oxygenation (ECMO) for neonatal and pediatric cardiac and/or respiratory failure is well established, and its use for adult respiratory failure is rapidly increasing. Management strategies developed over the past 30 years coupled with significant recent technological advances have led to improved ECMO survival. These new technologies are expanding the potential applications for ECMO in exciting ways, including new patient populations and the ability to make ECMO mobile for both intra- and inter-hospital transport. In this article, we highlight some of the recent technological advances and their impact on the utilization of ECMO in increasingly diverse patient populations.
体外膜肺氧合（ECMO）在新生儿和儿科心脏和/或呼吸衰竭中的应用已得到充分证实，其在成人呼吸衰竭中的应用也在迅速增加。过去 30 年来发展起来的管理策略，加上最近的重大技术进步，使 ECMO 的存活率得到了提高。这些新技术以令人兴奋的方式扩展了 ECMO 的潜在应用，包括新的患者群体以及使 ECMO 在院内和院际转运中变得更加移动的能力。在本文中，我们强调了一些最近的技术进步及其对 ECMO 在越来越多样化的患者群体中的应用的影响。
